Introduction About MOQ4 LP EYE DROPS

MOQ4 LP EYE DROPS is a combination of Loteprednol and Moxifloxacin which belongs to the group of medicines called Corticosteroids and Antibiotics respectively. MOQ4 LP EYE DROPS is used in the management of postoperative steroid responsive inflammatory ocular infections or risk of bacterial ocular infections exists.

Before using MOQ4 LP EYE DROPS, your doctor may want you to take relevant tests to understand your existing condition. Do not wear contact lenses if you have an active eye infection or while using this medicine.

MOQ4 LP EYE DROPS is not recommended for use in patients with viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.

Before using MOQ4 LP EYE DROPS, inform your doctor if you have diabetes, increased pressure in the eye, glaucoma, damage of nerves supplying the eye, any visual disturbances, cataract, delay in healing, pus discharge from the eye.

There are no adequate data available for the use of MOQ4 LP EYE DROPS during pregnancy, lactation and in infants. Consult your doctor before using this medicine.

Prolonged use of MOQ4 LP EYE DROPS may result in overgrowth of non-susceptible organisms, including fungi. Cataract formation and delayed wound healing can happen with prolonged usage.  

The most common side effects of using MOQ4 LP EYE DROPS are decreased visual acuity, dry eye, keratitis, ocular discomfort, ocular hyperemia, ocular pain, ocular pruritus, sub-conjunctival hemorrhage, tearing, optic nerve damage. Consult your doctor if any of the above side effects worsen.

Uses Of MOQ4 LP EYE DROPS

• Used in the management of postoperative steroid responsive inflammatory ocular infections or risk of bacterial ocular infections exists

How MOQ4 LP EYE DROPS Works

MOQ4 LP EYE DROPS is a combination of Loteprednol and Moxifloxacin. Loteprednol belongs to steroid which blocks the production of certain chemical messengers (prostaglandins) that make the eye red, swollen and itchy. Moxifloxacin belongs to antibiotic which manages bacterial cells from dividing and repairing, thereby works against the bacteria.

How to use MOQ4 LP EYE DROPS

Use MOQ4 LP EYE DROPS as directed by your doctor. It is for ophthalmic use only. Instill one to two drops into the eye as advised by your doctor. Avoid touching the nostril tip of the medicine with your hands or eye surface to avoid contamination.

Side Effects Of MOQ4 LP EYE DROPS

Warning & Precautions

Pregnancy

There are no adequate data available date for the use of MOQ4 LP EYE DROPS during pregnancy. Consult your doctor for advice.

Breastfeeding

There are no adequate data available date for the use of MOQ4 LP EYE DROPS during breastfeeding. Consult your doctor for advice.

Driving and Using Machines

Do not drive or operate any machines if you are experience blurred or impaired vision after using MOQ4 LP EYE DROPS.

Allergy

Do not use MOQ4 LP EYE DROPS if you are allergic to Loteprednol, Moxifloxacin or any other ingredients of this medicine.

Interactions

A. Drug-Drug interactions:

Before using MOQ4 LP EYE DROPS inform your doctor if you are taking any of the following medicines:

• cycloplegics (medicines that paralyze the ciliary muscles and cause relaxation of accommodation)

Overdosage:

If you or anyone else accidentally uses too much of MOQ4 LP EYE DROPS, rinse your eyes externally with clean/lukewarm water and consult your doctor immediately or visit the nearby hospital.

Synopsis

More Information

• Keep out of reach from children
• Store at room temperature

FAQs About MOQ4 LP EYE DROPS

Q: Is [GBBNKEYWORD] safe for use in patients with viral infections?

A: Patients with a viral disease (such as varicella, vaccinia, herpes simplex, and other viral infections of the eye) or fungal infection of the eye should not use MOQ4 LP EYE DROPS. Consult your doctor before using it.

Q: Is [GBBNKEYWORD] safe for use during pregnancy and breastfeeding?

A: There are no adequate data available for the use of MOQ4 LP EYE DROPS during pregnancy and lactation. Consult your doctor before using this medicine.

Q: What to do if [GBBNKEYWORD] accidentally used in excess?

A: If you or anyone else have accidentally used MOQ4 LP EYE DROPS in excess, rinse the external surface of the eye with lukewarm water immediately. Consult your doctor immediately or visit the nearby hospital immediately if you are experiencing worsening symptoms.

Q: Can I drive after using [GBBNKEYWORD]?

A: Do not drive or operate any machinery if you experience blurred or impaired vision after using MOQ4 LP EYE DROPS.

References

1. KD. Tripathi. Antimicrobial drugs, NSAIDs and antipyretic-analgesics. Essentials of medical pharmacology. 8th Edition. 2019. Page –219, 764.

2. Darlene Miller. National Library of Medicine (NIH). Review of Moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. [Revised on March 2008] [Accessed on 17th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698721/

3. Michael and Massimo Busin. National Library of Medicine (NIH). Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. [Revised on 16th June 2012] [Accessed on 17th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459083/

4. Novartis Ireland Limited. Electronic Medicines Compendium (EMC). Moxivig 0.5% w/v eye drops, solution. [Revised on October 2021] [Accessed on 17th May 2022] https://www.medicines.org.uk/emc/files/pil.5721.pdf

5. Bausch Health Poland sp. Electronic Medicines Compendium (EMC). Yellox 0.9 mg/ml eye drops, solution, Bromfenac. [Revised on February 2021] [Accessed on 17th May 2022] https://www.medicines.org.uk/emc/product/6212/pil

6. Bausch & Lomb Incorporated. U.S. Food and Drug Administration (FDA). [Revised on September 2012] [Accessed on 17th May 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202872lbl.pdf

7. Micro labs Ltd. [Accessed on 17th May 2022] http://www.microlabsltd.com/elibrary/node/1811

Author Details

Written By Dr. Janet.C - Pharm.D

Reviewed By Dr. Sankara Babu Gorle - MBBS, MD(Pharmacology) View profile

Last updated on 14 Jan 2023 | 02:56 PM(IST)